Yasuo Hamamoto Selected Research

Yasuo Hamamoto Research Topics

Disease

33	Neoplasms (Cancer) 08/2023 - 09/2000
23	Stomach Neoplasms (Stomach Cancer) 10/2023 - 09/2000
18	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 05/2005
14	Neoplasm Metastasis (Metastasis) 11/2023 - 09/2000
12	Esophageal Squamous Cell Carcinoma 03/2023 - 11/2013
12	Disease Progression 01/2021 - 09/2000
10	Esophageal Neoplasms (Esophageal Cancer) 10/2021 - 06/2011
6	Neutropenia 02/2021 - 10/2013
6	Pancreatic Neoplasms (Pancreatic Cancer) 10/2018 - 06/2010
5	Renal Cell Carcinoma (Grawitz Tumor) 08/2023 - 01/2011
4	Infections 02/2021 - 01/2011
4	Adenocarcinoma 06/2020 - 09/2012
4	Carcinoma (Carcinomatosis) 01/2017 - 05/2005
4	Anorexia 12/2013 - 06/2012
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2023 - 01/2020
3	Melanoma (Melanoma, Malignant) 08/2023 - 01/2020
3	Pneumonia (Pneumonitis) 08/2023 - 01/2011
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023 - 11/2016
3	Stomatitis 10/2021 - 01/2011
3	Hand-Foot Syndrome 02/2019 - 11/2014
3	Anemia 01/2019 - 04/2010
3	Lymphatic Metastasis 09/2018 - 09/2000
3	Diarrhea 07/2018 - 11/2014
3	Hemorrhage 04/2016 - 04/2002
2	Ulcerative Colitis 10/2021 - 03/2021
2	Enterocolitis 03/2021 - 02/2020
2	Febrile Neutropenia 02/2021 - 07/2016
2	Ascites 06/2020 - 01/2020
2	Hypertension (High Blood Pressure) 01/2019 - 02/2015
2	Hypersensitivity (Allergy) 07/2018 - 04/2015
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 11/2016
2	Colonic Neoplasms (Colon Cancer) 02/2013 - 05/2011
2	Fever (Fevers) 06/2012 - 12/2004
1	Hyperammonemia 11/2023
1	Brain Diseases (Brain Disorder) 11/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2023
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 11/2023
1	Residual Neoplasm 01/2022
1	Coinfection 10/2021
1	Immediate Hypersensitivity 07/2021

Drug/Important Bio-Agent (IBA)

18	Fluorouracil (Carac)FDA LinkGeneric 12/2022 - 09/2000
15	NivolumabIBA 10/2023 - 01/2017
15	Cisplatin (Platino)FDA LinkGeneric 02/2021 - 09/2000
9	Immune Checkpoint InhibitorsIBA 08/2023 - 07/2018
9	Irinotecan (Camptosar)FDA LinkGeneric 12/2022 - 04/2008
6	Docetaxel (Taxotere)FDA Link 02/2021 - 11/2013
6	Bevacizumab (Avastin)FDA Link 05/2018 - 10/2010
6	Capecitabine (Xeloda)FDA Link 05/2018 - 10/2010
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2022 - 10/2010
5	Paclitaxel (Taxol)FDA LinkGeneric 06/2020 - 06/2011
5	Trastuzumab (Herceptin)FDA Link 01/2020 - 04/2012
4	Leucovorin (Folinic Acid)FDA Link 12/2022 - 04/2008
4	AntibodiesIBA 07/2021 - 09/2012
4	PlatinumIBA 11/2019 - 06/2011
4	Gemcitabine FDA Link 10/2018 - 06/2010
3	pembrolizumabIBA 08/2023 - 01/2020
3	InterferonsIBA 07/2018 - 06/2012
3	SteroidsIBA 07/2018 - 01/2011
3	Monoclonal AntibodiesIBA 12/2017 - 05/2009
3	Sorafenib (BAY 43-9006)FDA Link 02/2015 - 01/2011
2	Sunitinib (Sutent)FDA Link 11/2023 - 01/2011
2	Tyrosine Kinase InhibitorsIBA 11/2023 - 01/2016
2	atezolizumabIBA 08/2023 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 05/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2022 - 02/2015
2	CreatinineIBA 02/2021 - 01/2017
2	RamucirumabIBA 06/2020 - 01/2019
2	regorafenibIBA 01/2020 - 01/2016
2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 05/2009
2	Immunoglobulin G (IgG)IBA 01/2019 - 12/2017
2	Proteins (Proteins, Gene)FDA Link 12/2018 - 01/2013
2	EnzymesIBA 07/2018 - 04/2015
2	Peptides (Polypeptides)IBA 07/2018 - 04/2015
2	Panitumumab (Vectibix)FDA Link 06/2016 - 05/2009
2	Methotrexate (Mexate)FDA LinkGeneric 10/2013 - 09/2000
2	Cetuximab (Erbitux)FDA Link 02/2013 - 06/2011
2	XELOXIBA 04/2011 - 10/2010
2	Everolimus FDA Link 01/2011 - 04/2010
2	Complementary DNA (cDNA)IBA 06/2007 - 05/2005
1	SodiumIBA 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	Antimicrobial PeptidesIBA 10/2021
1	Qingdai compoundIBA 10/2021
1	Indigo Carmine (Indigo Blue)IBA 10/2021
1	Serum AlbuminIBA 07/2021
1	Capsules (Microcapsules)IBA 03/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2021
1	tributyl phosphate (TBP)IBA 01/2021
1	130-nm albumin-bound paclitaxelIBA 06/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 05/2020

Therapy/Procedure

39	Drug Therapy (Chemotherapy) 08/2023 - 09/2000
33	Therapeutics 01/2023 - 09/2000
5	Chemoradiotherapy 01/2022 - 06/2010
4	Salvage Therapy 11/2023 - 06/2016
4	Induction Chemotherapy 02/2021 - 11/2016
3	Radiotherapy 01/2019 - 04/2016
2	Neoadjuvant Therapy 03/2023 - 01/2022
2	Lymph Node Excision (Lymph Node Dissection) 01/2019 - 09/2018
2	Combination Drug Therapy (Combination Chemotherapy) 12/2013 - 10/2010
2	Adjuvant Chemotherapy 05/2011 - 09/2000